Developmental programming: influence of sex steroids and mechanisms
Developmental programming: influence of sex steroids and mechanisms
批准号:
8383460
负责人:
CHANDRASEKHAR YALLAMPALLI
金额:
$36.41万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2013-08-31
关键词:
AddressAdultAffectAngiotensinsAntiandrogen TherapyBlood PressureBlood VesselsCardiovascular PhysiologyCell physiologyChymosinDataDevelopmentDiseaseEndocrineEndothelial CellsEnvironmentEnvironmental Risk FactorEpidemiologyEstradiolExposure toFemaleFetal DevelopmentFlutamideFunctional disorderGenderGoalsGonadal Steroid HormonesGrowthHealthHormonesHumanHypertensionMesenteric ArteriesModelingMuscle functionObesityOrchiectomyOrganismOvariectomyPerinatal ExposurePlasmaPopulationPredispositionPrevention strategyProteinsRegulationRegulatory PathwayRenin-Angiotensin SystemReportingRiskRoleSeveritiesSexual DevelopmentSmooth MuscleSmooth Muscle MyocytesSteroid ReceptorsSteroidsSystemTestosteroneVariantVascular EndotheliumVascular Smooth Muscleage relatedcritical periodfetal programminghypertension treatmentin uteroinsightmaleoffspringpressurepreventprogramssexsteroid hormonesteroid hormone receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Adverse intrauterine environment during the critical period of fetal development predisposes organisms to
increased risk for developing hypertension. We and others using a low-protein (LP) model of fetal programming
demonstrated that hypertension in offspring is gender related, with a greater effect in males than females, and
endocrine changes may underlie the development of hypertension. The central hypothesis is that sex
steroid hormones, testosterone (T) and estradiol (E2), via interaction with a variety of regulatory path-
ways, regulate the development and progression of maternal LP-induced hypertension in the offspring.
Effects include changes in vascular steroid receptors, endothelial and smooth muscle (VSM) function,
and vascular rennin angiotensin system (RAS). Three specific aims are proposed. Specific Aim 1:
Investigate the influence of sex steroids on maternal LP-induced developmental origins of hypertension in male
and female offspring. Specific Aim 1a. Is the onset and severity of hypertension related to changes in sex
steroids? We hypothesize that endocrine dysfunction will precede the development of hypertension with a
more pronounced effect in males than females. Specific Aim 1b. Are alterations in blood pressure (BP) in the
offspring specific to changes in the levels of sex steroids? We hypothesize that OVX in females exacerbates,
while OCX in males dampens, the onset and severity of hypertension, and these changes are reversed by
respective steroid replacement and flutamide. Growth rate, adiposity, and changes in MAP and plasma T and
E2 will be assessed. Specific Aim 2: Characterization of endothelial and VSM cell functions and their
regulation by sex steroids in hypertensive offspring. We hypothesize that endocrine dysfunction will alter
expression of steroid receptors, endothelial, and VSM functions in LP offspring, and these effects are hormone
specific. Specific Aim 2a. Are alterations in BP in the offspring specific to changes in the levels of sex steroid
receptors? Specific Aim 2b. Is endothelial cell function altered and related to changes in T and E2 levels in
hypertensive offspring? Specific Aim 2c. Is VSM cell function altered and related to changes in T and E2 levels
in hypertensive offspring? Specific Aim 2d. Are alterations in the function of endothelium and VSM specific to
changes in T and E2 levels in hypertensive offspring? Specific Aim 3: Characterization of vascular RAS
function and regulation by sex steroids in hypertensive offspring. We hypothesize that alteration in T and E2
levels will alter expression and activity of RAS components, and thus BP, in LP offspring. Specific Aim 3a. Is
the function and expression of RAS components altered with age and related to changes in T and E2 levels in
the hypertensive offspring? Specific Aim 3b. Are the expression and activity of RAS components in hyper-
tensive offspring specific to changes in T and E2 using gonadectomy in LP offspring? The study will assess if
these changes are reversed with respective hormones and flutamide. Collectively, these studies will yield
important insights that could aid in developing sex-specific strategies for preventing and treating hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental programming: influence of sex steroids and mechanisms
-
批准号:8751210
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2010
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Developmental programming: influence of sex steroids and mechanisms
-
批准号:8197579
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Developmental programming: influence of sex steroids and mechanisms
-
批准号:8056426
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Nitric oxide regulation of CD55 and infection
-
批准号:8206846
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2009
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Nitric oxide regulation of CD55 and infection
-
批准号:8403523
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2009
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Nitric oxide regulation of CD55 and infection
-
批准号:8794626
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2009
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Nitric oxide regulation of CD55 and infection
-
批准号:8004069
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2009
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Nitric oxide regulation of CD55 and infection
-
批准号:7759623
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2009
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Low birth weight, uterine infection, and nitric oxide
-
批准号:6695283
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2002
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Low birth weight, uterine infection, and nitric oxide
-
批准号:7151219
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2002
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Low birth weight, uterine infection, and nitric oxide
-
批准号:7064798
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2002
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Low birth weight, uterine infection, and nitric oxide
-
批准号:6581490
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2002
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Low birth weight, uterine infection, and nitric oxide
-
批准号:6829112
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2002
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Ontogeny of CRLR and RAMPs in Myometrium
-
批准号:6536393
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2001
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Ontogeny of CRLR and RAMPs in Myometrium
-
批准号:6359245
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2001
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
SEX STEROID HORMONES AND CALCITONIN GENE RELATED PEPTIDE
-
批准号:6125838
-
项目类别:
-
资助金额:$31.69万
-
财政年份:1997
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Sex Steroid Hormones and Calcitonin Gene-Related Peptide
-
批准号:7143194
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1997
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Sex Steroid Hormones and Calcitonin Gene-Related Peptide
-
批准号:6829119
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1997
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Sex Steroid Hormones and Calcitonin Gene-Related Peptide
-
批准号:6682352
-
项目类别:
-
资助金额:$29.8万
-
财政年份:1997
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
Sex Steroid Hormones and Calcitonin Gene-Related Peptide
-
批准号:7228917
-
项目类别:
-
资助金额:$32.99万
-
财政年份:1997
-
负责人:CHANDRASEKHAR YALLAMPALLI
-
依托单位:
海外基金